ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) announced that its Board of Directors has unanimously approved the termination of the Company’s Section ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE